Clinical case of methotrexate overdose, the peculiarity of diagnostics in the conditions of the COVID-19 pandemic-Reference-Cited by-同舟云学术

Clinical case of methotrexate overdose, the peculiarity of diagnostics in the conditions of the COVID-19 pandemic

Published:2023-06-01 Issue:4-5 Volume:101 Page:241-246
ISSN:2412-1339
Container-title:Clinical Medicine (Russian Journal)
language:
Short-container-title:jour

Author:

Zaborskikh I. V.¹,Simonenko V. B.²,Sarmanaev S. Kh.³^ORCID,Tuktarova R. R.⁴^ORCID,Yurina Yu. O.⁵

Affiliation:

1. City Hospital No. 2 of Miass Multidisciplinary Medical Center “Severny”

2. Military Medical Academy named after S.M. Kirov (Moscow branch) of the Ministry of Defense of Russia

3. Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Academy of Postgraduate Education of the Federal State Budgetary Institution “Federal Scientifi c and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency”

4. City Clinical Hospital No. 21 Ufa

5. Academy of Postgraduate Education of the Federal State Budgetary Institution “Federal Scientifi c and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency”

Abstract

The diversity and low specifi city of clinical manifestations of COVID-19, as well as its widespread prevalence, present diffi culties for diff erential diagnosis, including conditions caused by drug overdose. The challenging experience of providing medical care during the coronavirus pandemic draws attention to the importance and necessity of further improving its diagnosis, especially in comorbid conditions. A clinical case of diff erential diagnosis of non- iatrogenic overdose of methotrexate in a patient with a preliminary diagnosis (virus unknown) is described: U07.2 (ICD-10) COVID-19.

Publisher

Medical Informational Agency Publishers

Subject

General Medicine

Reference26 articles.

1. Tu H., Tu S., Gao S., Shao A., Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J. Infect. 2020;81(1):1–9. DOI: 10.1016/j.jinf.2020.04.011

2. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции COVID-19. Версия 17 (14.12.2022), МЗ РФ. -260 с.

3. Ge H., Wang X., Yuan X., Xiao G., Wang C., Deng T. et al. The epidemiology and clinical information about COVID-19. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39(6):1011–9. DOI: 10.1007/s10096-020-03874-z

4. Ayalon I., Friedman S., Binenbaum Y., Oppenheimer N., Shiran S., Grisaru-Soen G. et al. A case of methotrexate neurotoxicity presented as status epilepticus, encephalopathy, and high fever. J. Investig. Med. High Impact Case Rep. 2019;7:2324709619862311. DOI: 10.1177/2324709619862311

5. Pannu A.K. Methotrexate overdose in clinical practice. Curr. Drug. Metab. 2019;20(9):714–9. DOI: 10.2174/1389200220666190806140844